PM reduces cellular oxidative stress through inhibition of mitogen-activated protein kinase’s (MAPK) activation and p-53 and p38 mediated apoptosis signalling pathway, thereby reducing liver-steatosis, inflammation and apoptosis (7). Here, TP53 is linked to steatosis.